IMARC Group has recently released a new research study titled “Self-Healing Concrete Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
What are the growth prospects of the self-healing concrete industry?
The global self-healing concrete market size reached US$ 34.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 153.7 Billion by 2027, exhibiting a growth rate (CAGR) of 28.35% during 2022-2027.
What is Self-Healing Concrete ?
Self-healing concrete is an artificial building material that automatically mends cracks and damages. It contains a bacterium that produces limestone, which then expands to form a gel upon coming into contact with air and water to fill gaps. Self-healing concrete closes the cracks to safeguard the steel framework from any external impacts and reduces corrosion risk. This concrete is usually available in autonomic and autogenic self-healing variants. The autogenous cement utilizes moisture to ensure the healing process, whereas the autonomous cement uses tablets containing bacteria spores or additional healing agents. Consequently, it is used extensively for constructing industrial, residential, civil, and commercial infrastructures.
Request Free Sample Report: https://www.imarcgroup.com/self-healing-concrete-market/requestsample
Market Trends
Substantial growth in the construction industry worldwide primarily drives the market for self-healing concrete. Furthermore, the increasing demand for reliable, environment-friendly, and durable constructions also augmenting the market growth. Additionally, the extensive adoption of vascular-based healing technologies to construct modern buildings is further catalyzing the product demand. These technologies involve a network of tubes containing self-healing concrete that is passed through the building walls to reinforce the infrastructure. Moreover, the emergence of several product innovations, such as the development of capsule-based self-healing concrete, will continue to drive the market growth in the coming years.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=3393&flag=C
List of Key Companies Covered in this Market Report:
BASF SE (ETR: BAS)
Basilisk
CEMEX S.A.B. de C.V. (NYSE: CX)
GCP Applied Technologies Inc. (NYSE: GCP)
Hycrete Inc. (Broadview Technologies Inc.)
Kryton International Inc.
Oscrete (Christeyns UK Ltd.)
Penetron
RPM International Inc. (NYSE: RPM)
Sika AG (SWX: SIKA)
Xypex Chemical Corporation.
The report has segmented the market on the basis of form, application and geography.
Breakup by Form:
Intrinsic
Capsule Based
Vascular
Breakup by Application:
Residential
Industrial
Commercial
Breakup by Geography:
North America (U.S. & Canada)
Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
Latin America (Brazil, Mexico)
Middle East & Africa
Key highlights of the report:
Market Performance (2016-2021)
Market Outlook (2022- 2027)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
